학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 890건 | 목록 1~20
Academic Journal
Cambon A; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Guervilly C; Centre d'Etudes et de Recherches sur les Services de Santé et qualité de vie EA 3279, Aix-Marseille Université, Marseille, France.; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique- Hôpitaux de Marseille, Chemin des Bourrely, Marseille, France.; Delteil C; Département de Médecine légale, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille University, Marseille, France.; Potere N; School of Medicine and Health Sciences, 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.; Bachelier R; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Tellier E; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Abdili E; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Service d'Hématologie et de Biologie vasculaire, CHU La Timone, APHM, Marseille, France.; Leprince M; Service de Médecine interne et d'Immunologie clinique, Assistance Publique - Hôpitaux de Marseille, Hôpital La Conception, Marseille, France.; Giani M; School of Medicine and Health Sciences, 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy.; Polidoro I; Unit of Legal Medicine, 'Santo Spirito' Hospital, Local Health Authority of Pescara, Pescara, Italy.; Albanese V; Unit of Legal Medicine, 'Santo Spirito' Hospital, Local Health Authority of Pescara, Pescara, Italy.; Ferrante P; Unit of Legal Medicine, 'Santo Spirito' Hospital, Local Health Authority of Pescara, Pescara, Italy.; Coffin L; AB2 Bio, Lausanne, Switzerland.; Schiffrin M; AB2 Bio, Lausanne, Switzerland.; Arnaud L; Service d'Hématologie et de Biologie vasculaire, CHU La Timone, APHM, Marseille, France.; Lacroix R; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Service d'Hématologie et de Biologie vasculaire, CHU La Timone, APHM, Marseille, France.; Roque S; Service de Médecine interne et d'Immunologie clinique, Assistance Publique - Hôpitaux de Marseille, Hôpital La Conception, Marseille, France.; Forel JM; Centre d'Etudes et de Recherches sur les Services de Santé et qualité de vie EA 3279, Aix-Marseille Université, Marseille, France.; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique- Hôpitaux de Marseille, Chemin des Bourrely, Marseille, France.; Hraiech S; Centre d'Etudes et de Recherches sur les Services de Santé et qualité de vie EA 3279, Aix-Marseille Université, Marseille, France.; Service de Médecine Intensive Réanimation, Hôpital Nord, Assistance Publique- Hôpitaux de Marseille, Chemin des Bourrely, Marseille, France.; Daniel L; Service d'Anatomopathologie, APHM, Aix Marseille University, Marseille, France.; Papazian L; Service de Réanimation, Centre Hospitalier de Bastia, Bastia, France.; Dignat-George F; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Service d'Hématologie et de Biologie vasculaire, CHU La Timone, APHM, Marseille, France.; Kaplanski G; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.; Service de Médecine interne et d'Immunologie clinique, Assistance Publique - Hôpitaux de Marseille, Hôpital La Conception, Marseille, France.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Gopalakrishnan V; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Sparklin B; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kim JH; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Bouquet J; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kehl M; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kenny T; Virology and Vaccine Discovery, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Morehouse C; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Caceres C; Translational Scientific Management, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Warrener P; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Hristova VA; Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Wilson S; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Shandilya H; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Barnes A; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Ruzin A; Translational Scientific Management, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Wang J; Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Oberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Angermann B; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Platt A; VP and Head of Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Muthas D; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Hess S; Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Tkaczyk C; Microbial Antibodies and Technologies, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Sellman BR; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Ostridge K; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; Belvisi MG; SVP and Head of Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wilkinson TMA; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Staples KJ; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; DiGiandomenico A; Microbial Antibodies and Technologies, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. antonio.digiandomenico@astrazeneca.com.
Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
Academic Journal
Wong SSW; Institut Pasteur, Molecular Mycology Unit, CNRS, UMR2000, Paris, France.; Daniel I; Department of Proteomics and Ocular Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.; Gangneux JP; University of Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.; Jayapal JM; Department of Proteomics and Ocular Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.; Guegan H; University of Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.; Dellière S; Institut Pasteur, Molecular Mycology Unit, CNRS, UMR2000, Paris, France.; Parasitology-Mycology Laboratory, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.; Lalitha P; Department of Ocular Microbiology, Aravind Eye Hospital, Madurai, Tamil Nadu, India.; Shende R; National Centre for Cell Sciences, University of Pune, Pune, Maharashtra, India.; Madan T; National Institute for Research in Reproductive Health, Indian Council of Medical Research, Mumbai, Maharashtra, India.; Bayry J; Institut National de la Santé et de la Recherche Médicale, Centre de Recherché des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.; Guijarro JI; Institut Pasteur, Biological NMR Technological Platform, CNRS UMR 3528, Paris, France.; Kuppamuthu D; Department of Proteomics and Ocular Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.; Aimanianda V; Institut Pasteur, Molecular Mycology Unit, CNRS, UMR2000, Paris, France vkumar@pasteur.fr.
Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5522 (Electronic) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Lavage, Daniel R
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어